Pages that link to "Q41533627"
Jump to navigation
Jump to search
The following pages link to Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine (Q41533627):
Displaying 15 items.
- Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial (Q28284031) (← links)
- Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. (Q30459974) (← links)
- Central histaminergic system and cognition (Q33828010) (← links)
- Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review (Q37856977) (← links)
- Attention deficits and hyperactivity (Q37978998) (← links)
- Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder (Q38028871) (← links)
- Catecholamines and attention. I: Animal and clinical studies (Q39694446) (← links)
- Biological Validation of the Hyperkinetic Syndrome (Q40085293) (← links)
- QTL association analysis of the DRD4 exon 3 VNTR polymorphism in a population sample of children screened with a parent rating scale for ADHD symptoms. (Q43621860) (← links)
- Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma (Q44448604) (← links)
- Relationship between stimulant effect, electroencephalogram, and clinical neurological findings in hyperactive children (Q45273355) (← links)
- Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects (Q47603171) (← links)
- Reliability of neurological soft signs in children: reevaluation of the PANESS. (Q48936574) (← links)
- Absence of linkage of apparently single gene mediated ADHD with the human syntenic region of the mouse mutant Coloboma (Q51007228) (← links)
- Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects (Q69517342) (← links)